← Back to Clinical Trials
Recruiting NCT06441422

NCT06441422 Blood Flow Restriction Training for People With Disabilities

◆ AI Clinical Summary
Plain-language summary for patients
Clinical Trial Summary
NCT ID NCT06441422
Status Recruiting
Phase
Sponsor Medical College of Wisconsin
Condition Weakness, Muscle
Study Type INTERVENTIONAL
Enrollment 24 participants
Start Date 2024-12-12
Primary Completion 2026-12-31

Eligibility & Interventions

Sex All sexes
Min Age 18 Years
Max Age N/A
Study Type INTERVENTIONAL
Interventions
Blood flow restriction trainingNo blood flow restriction training

Eligibility Fast-Check

Enter your details for a quick preliminary check. This does not replace medical advice.

What to Expect as a Participant

You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.

This trial targets 24 participants in total. It began in 2024-12-12 with a primary completion date of 2026-12-31.

⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.

Brief Summary

A large portion of the American population live with disabilities. People with disabilities can find it difficult to perform standard exercise routines. Regular exercise is necessary to be healthy, especially as people age. Lack of exercise can lead to secondary health concerns, like loss of muscle mass, diabetes, heart attack or stroke, to name a few. For exercise to be most beneficial, a certain degree of intensity must be achieved. Low load blood flow restriction training may be able to mimic the intensity of beneficial exercise without actually exercising hard. It may be a good option for people with disabilities who find it difficult to exercise.

Eligibility Criteria

Inclusion Criteria: * Male or female * Age \> or = 18 * English speaking * Able to understand and perform upper extremity exercises Exclusion Criteria: * Pregnant * Body mass index \>40 kg·m-2 * Uncontrolled hypertension (\>150/90 mmHg) * Presence of neuromuscular junction and other muscle diseases * Myocardial infarction in the past 6 months * Unstable cardiovascular disease * History of an upper limb deep vein thrombosis * History of autonomic dysreflexia * Upper extremity fracture within the last 6 months

Contact & Investigator

Central Contact

Beth Weinman, DO

✉ bweinman@mcw.edu

📞 414-955-1922

Frequently Asked Questions

Who can join the NCT06441422 clinical trial?

This trial is open to participants of all sexes, aged 18 Years or older, studying Weakness, Muscle. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.

Is NCT06441422 currently recruiting?

Yes, NCT06441422 is actively recruiting participants. Contact the research team at bweinman@mcw.edu for enrollment information.

Where is the NCT06441422 trial being conducted?

This trial is being conducted at Milwaukee, United States.

Who is sponsoring the NCT06441422 clinical trial?

NCT06441422 is sponsored by Medical College of Wisconsin. The trial plans to enroll 24 participants.

Related Trials

ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer  ·  Last Reviewed: September 2026  ·  Data Methodology